Form EFFECT Atara Biotherapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 25, 2026 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gores Holdings XI, Inc. Announces Pricing of $312 Million Initial Public Offering
- Samsung Unveils Industry's Fastest UFS 5.0 Solution for Next-Gen On-Device AI Applications
- Numetrica Highlights Key CRA Compliance Risks Facing Small Businesses
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
